SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment with IMA203 administered at the recommended phase 2 dose versus investigator's choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma. For patients interested in additional information on how to participate, please follow this link: https://mytomorrows.com/trials/suprame/en-us/
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony czerniak skóry, który się rozszerzył na inne części ciała lub nie da się go operować
- •Posiadanie specjalnego markera genetycznego (HLA-A*02:01)
- •Wcześniejsze leczenie lekami hamującymi PD-1 bez efektu lub z powodu skutków ubocznych
- •Oczekiwana długość życia ponad 6 miesięcy
- •Możliwość zmierzenia guza za pomocą badań obrazowych
- •Dobry ogólny stan zdrowotny (możliwość samodzielnej opieki nad sobą)
- •Gotowość do stosowania antykoncepcji przez okres leczenia i pół roku po nim
✗ Disqualifies
- •Czerniak błon śluzowych (jamy ustnej, nosa) lub oka
- •Inne nowotwory w ciągu ostatnich 3 lat (poza rakiem skóry basalioma)
- •Poważne choroby autoimmunologiczne
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (71)
Mayo Clinic
Phoenix, United States
Honor Health Research Institute
Scottsdale, United States
City of Hope National Medical Center
Duarte, United States
UC San Diego Moores Cancer Center
La Jolla, United States
UCLA Hematology/Oncology
Los Angeles, United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, United States
Stanford Cancer Center
Stanford, United States
University of Colorado, Anschutz Medical Campus
Aurora, United States
Yale Cancer Center
New Haven, United States
Mayo Clinic Florida
Jacksonville, United States
University of Miami - Sylvester Comprehensive Cancer Cente
Miami, United States
AdventHealth, Orlando
Orlando, United States
Moffitt Cancer Center
Tampa, United States
Winship Cancer Institute, Emory University
Atlanta, United States
University of Chicago Medical Center
Chicago, United States
University of MD Greenebaum Comprehensive Cancer Center
Baltimore, United States
Massachusetts General Hospital
Boston, United States
Beth Israel Deaconess Medical Center
Boston, United States
University of Michigan
Ann Arbor, United States
Mayo Clinic
Rochester, United States
University of Nebraska Medical Center
Omaha, United States
Atlantic Health System/Morristown Medical Center
Morristown, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
New York, United States
Memorial Sloan Kettering Cancer Center
New York, United States
University of Rochester
Rochester, United States
UNC Hospitals, The University of North Carolina at Chapel Hill
Chapel Hill, United States
Cleveland Clinic, Taussig Cancer Institute
Cleveland, United States
Ohio State University
Columbus, United States
Providence Cancer Institute Franz Clinic
Portland, United States
Lehigh Valley Topper Cancer Institute
Allentown, United States
University of Pennsylvania, Abramson Cancer Center
Philadelphia, United States
Thomas Jeffersion University, Sidney Kimmel Cancer Center
Philadelphia, United States
Fox Chase Cancer Center
Philadelphia, United States
UPMC Hillman Cancer Center
Pittsburgh, United States
Avera Cancer Institute
Sioux Falls, United States
SCRI Oncology Partners
Nashville, United States
Baylor University
Dallas, United States
University of Texas Southwestern Medical Center
Dallas, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
Huntsman Cancer Institute, University of Utah
Salt Lake City, United States
Virginia Commonwealth University
Richmond, United States
Fred Hutchinson Cancer Center
Seattle, United States
University of Wisconsin
Madison, United States
Cross Cancer Institute, Alberta
Edmonton, Canada
BC Cancer - Vancouver
Vancouver, Canada
University Health Network, Princess Margaret Cancer Centre
Toronto, Canada
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Canada
Centre Hospitalier Universitaire De Lille
Lille, France
Assistance Publique Hopitaux De Paris, Hôpital Saint Louis
Paris, France
Institut Gustave Roussy
Villejuif, France
Universitatsklinikum Koeln
Cologne, Germany
Charite Universitaetsmedizin Berlin KöR
Berlin, Germany
Universitaetsklinikum Bonn AöR
Bonn, Germany
Technische Universitaet Dresden
Dresden, Germany
Universitaetsklinikum Erlangen AöR
Erlangen, Germany
Universitaetsklinikum Essen AöR
Essen, Germany
Goethe University Frankfurt
Frankfurt am Main, Germany
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Universitaetsklinikum Heidelberg AöR
Heidelberg, Germany
Universitaet Leipzig
Leipzig, Germany
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Mainz, Germany
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Amsterdam, Netherlands
Universitair Medisch Centrum Groningen
Groningen, Netherlands
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Rotterdam, Netherlands
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
Cambridge, United Kingdom
Greater Glasgow and Clyde NHS, Beatson West of Scotland Cancer Center
Glasgow, United Kingdom
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital
London, United Kingdom
The Royal Marsden NHS Foundation Trust
London, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Oxford, United Kingdom
University of Southampton NHS Foundation Trust, Southampton General Hospital
Southampton, United Kingdom
Trial contact
Immatics US, Inc.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.